Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics

We explored the effects of chitosan oligosaccharides (COS) on coronary heart disease (CHD) patients. The component of COS was measured by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). CHD patients were evenly assigned into the COS group (COG) and the pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Tiechao, Xing, Xiaohong, Zhang, Lirong, Liu, Zhen, Zhao, Jixue, Liu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431530/
https://www.ncbi.nlm.nih.gov/pubmed/30984339
http://dx.doi.org/10.1155/2019/7658052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431530/
https://www.ncbi.nlm.nih.gov/pubmed/30984339
http://dx.doi.org/10.1155/2019/7658052

Ejemplares similares